Aug 16 (Reuters) - GSK plc:
* STATEMENT: ZANTAC (RANITIDINE) U.S. LITIGATION
* NOTICE OF VOLUNTARY DISMISSAL TO BE FILED IN BAYER CASE, FIRST SCHEDULED ZANTAC TRIAL
* GSK DID NOT SETTLE BAYER’S CLAIM AND HAS NOT PAID ANYTHING IN EXCHANGE FOR THE VOLUNTARY DISMISSAL
* GSK WILL CONTINUE TO VIGOROUSLY DEFEND ITSELF AGAINST ALL CLAIMS ALLEGING CANCER RISK ASSOCIATED WITH THE USE OF RANITIDINE Source text for Eikon: Further company coverage: